New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement
FBT
US Health Care
Passive
NYSE listed

First Trust NYSE Arca Biotechnology Index Fund ETF

This ETF provides exposure to Equally Weighted US Biotechnology Equities

FBT performance and flow charts

Last update 10/28/2026 at 1:30 PM
Live
Closed
Last price
$279.17
+$5.44 (+1.99%) Today

Performance

-5.0-4.0-3.0-2.0-1.00.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Flows

0 M10 M20 M30 M40 M
1 day price range
$276.17
$280.03
52 week price range
$188.38
$274.06
1W perf
+0.64%
YTD perf
+32.86%
YTD flows
+$1.00B
AuM
$3.02B
E/R
0.54%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 27, 2026
1M3MYTD1Y3Y5Y
Perf.+0.05%+10.82%+32.86%+43.61%+107.80%+69.29%
Flows+$40M-$22M+$1.00B+$1.09B+$723M+$356M
Data as of October 27, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The First Trust NYSE Arca Biotechnology Index Fund ETF is built to track the NYSE Arca Biotechnology Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderFirst Trust
N° of holdings30
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 19, 2006
ESGNo
TrackinsightTrackinsight

More data and info about FBT on Trackinsight

Exposure

Data as of August 31, 2026

Diversification

55.27%

Total weight of top 15 holdings out of 30

Top 15 Holdings

Halozyme Therapeutics, Inc.
4.38%
Regeneron Pharmaceuticals, Inc.
3.84%
NeoGenomics, Inc.
3.83%
Corcept Therapeutics, Inc.
3.82%
Amgen, Inc.
3.74%
BeOne Medicines Ltd.
3.72%
Natera, Inc.
3.68%
Repligen Corp.
3.65%
argenx SE
3.63%
Gilead Sciences, Inc.
3.58%
Genmab A/S
3.56%
Vertex Pharmaceuticals, Inc.
3.5%
Sarepta Therapeutics, Inc.
3.49%
BioNTech SE
3.45%
BioMarin Pharmaceutical, Inc.
3.4%

Sectors

Healthcare
99.86%
Other
0.14%

Countries

USA
82.68%
Other
17.32%
Advertisement

Trading data

Last sale
10/28/2026 at 1:30 PM
$279.17
Previous close
$273.73
Consolidated volume
10/27/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+22.67%+22.17%+21.18%+22.27%
Max drawdown
-5.30%-14.27%-19.92%-27.40%
Max drawdown duration
61d126d237d1017d
Time to recover
N/A63d176d795d

Replication quality

Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about FBT

What type of ETF is FBT?

FBT is a Passive ETF that provides exposure to Equity assets. It is managed by First Trust.

What index does FBT track?

FBT tracks the NYSE Arca Biotechnology Total Return Index - USD, aiming to replicate its performance through full replication.

What does FBT invest in?

This ETF provides exposure to Equally Weighted US Biotechnology Equities. It is part of the segment: US Health Care.

What is the expense ratio of FBT?

The total expense ratio (TER) of FBT is 0.54%, representing the annual fee charged by the fund manager.

When was FBT launched?

FBT was launched on June 19, 2006, marking its entry into the ETF market.

Who is the issuer of FBT?

FBT is issued by First Trust.

What is the AUM of FBT?

As of October 27, 2026, FBT manages $3.02 B, reflecting the total assets held in the fund.

How has FBT performed recently?

As of October 27, 2026, FBT delivered a return of 0.05% over the past month (1M performance), 10.82% over the past three months (3M), and 32.86% year-to-date (YTD).

What are the recent fund flows for FBT?

As of October 27, 2026, FBT has seen net flows of +$40M in the past month (1M flow) and +$1.00B year-to-date (YTD).

How many holdings are in FBT

As of August 31, 2026, FBT holds 30 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is FBT?

As of August 31, 2026, FBT holds 30 securities, with 55.27% of its assets concentrated in its top 15 holdings.

What are the top holdings of FBT?

As of August 31, 2026, FBT holds a portfolio of 30 underlyings, with its largest positions including Halozyme Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. and NeoGenomics, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does FBT invest in?

As of August 31, 2026, FBT has its largest geographic exposures in USA.

What sectors or themes does FBT focus on?

As of August 31, 2026, FBT is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026